Cerus (NASDAQ:CERS) versus BZAM (OTCMKTS:BZAMF) Head to Head Analysis

BZAM (OTCMKTS:BZAMF) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings.

Volatility and Risk

BZAM has a beta of 5.82, suggesting that its share price is 482% more volatile than the S&P 500. Comparatively, Cerus has a beta of 1.7, suggesting that its share price is 70% more volatile than the S&P 500.

Profitability

This table compares BZAM and Cerus’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BZAM	N/A	N/A	N/A
Cerus	-9.81%	-33.77%	-9.32%

Analyst Ratings

This is a breakdown of current recommendations and price targets for BZAM and Cerus, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BZAM	0	0	0	0	0.00
Cerus	1	0	1	0	2.00

Cerus has a consensus target price of $4.00, indicating a potential upside of 172.11%. Given Cerus’ stronger consensus rating and higher possible upside, analysts clearly believe Cerus is more favorable than BZAM.

Valuation & Earnings

This table compares BZAM and Cerus”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BZAM	$37.96 million	0.00	-$27.31 million	($0.27)	N/A
Cerus	$180.27 million	1.56	-$20.92 million	($0.10)	-14.70

Cerus has higher revenue and earnings than BZAM. Cerus is trading at a lower price-to-earnings ratio than BZAM, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

0.0% of BZAM shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 8.7% of BZAM shares are held by insiders. Comparatively, 5.6% of Cerus shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Cerus beats BZAM on 7 of the 12 factors compared between the two stocks.

About BZAM

BZAM Ltd. operates as a cannabis producer with a focus on branded consumer goods. Its brands include the BZAM, TGOD, ness, Highly Dutch Organic, and TABLE TOP, as well as Dunn Cannabis, FRESH, and Wyld partner brands. The company operate facilities in British Columbia, Alberta, Ontario, and Quebec, as well as retail stores in Winnipeg, Manitoba and Regina, Saskatchewan. The company was formerly known as The Green Organic Dutchman Holdings Ltd. and changed its name to BZAM Ltd. in February 2023. The company was incorporated in 2016 and is headquartered in Vancouver, Canada.

About Cerus

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.